Cinemark (CNK) Financials

$27.64 -0.09 (-0.32%)

As of 01:06 PM Eastern

Annual Income Statements for Cinemark

This table shows Cinemark's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	217	255	264	214	191	-1,310	-423	-271	188	310	138
Consolidated Net Income / (Loss)	219	257	266	215	194	-1,843	-1,225	-765	400	637	290
Net Income / (Loss) Continuing Operations	219	257	266	215	194	-1,312	-751	-519	44	363	27
Total Pre-Tax Income	348	361	345	311	274	-2,766	-1,290	-772	680	774	517
Total Operating Income	423	423	392	388	338	-1,568	0.00	0.00	0.00	0.00	0.00
Total Gross Profit	2,087	2,117	2,143	2,334	2,320	-290	1,045	1,709	2,261	2,246	2,293
Total Revenue	2,853	2,919	2,992	3,222	3,283	0.00	1,511	2,455	3,067	3,050	3,115
Operating Revenue	2,702	2,919	2,992	3,222	3,283	-	1,511	2,455	3,067	3,050	3,115
Total Cost of Revenue	765	802	849	888	963	290	466	745	806	804	822
Operating Cost of Revenue	765	802	849	888	963	290	466	745	806	804	822
Total Operating Expenses	1,664	1,694	1,750	1,945	1,982	1,491	1,701	2,055	1,973	1,945	2,050
Selling, General & Admin Expense	513	499	508	613	648	712	885	1,167	1,328	1,351	1,438
Marketing Expense	946	963	967	1,000	1,004	-	0.00	0.00	0.00	0.00	0.00
Depreciation Expense	189	209	238	261	261	779	796	715	629	593	606
Impairment Charge	8.80	2.84	15	32	57	-	21	174	17	1.50	6.50
Other Special Charges / (Income)	8.14	20	23	39	12	-	0.00	0.00	0.00	0.00	0.00
Total Other Income / (Expense), net	-75	-62	-47	-78	-65	-453	-160	-180	-155	-113	-130
Interest Expense	114	122	106	131	129	376	149	202	196	188	185
Interest & Investment Income	37	38	42	50	54	-68	13	37	98	94	75
Other Income / (Expense), net	1.35	21	17	3.73	9.48	-9.60	-23	-16	-58	-19	-20
Income Tax Expense	129	104	79	95	80	-922	-66	-7.10	88	-176	86
Net Income / (Loss) Attributable to Noncontrolling Interest	1.86	1.74	1.84	1.48	2.46	-2.20	1.20	6.40	6.60	6.40	6.60
Basic Earnings per Share	$1.87	$2.19	$2.26	$1.83	$1.63	($10.50)	($7.10)	($4.52)	$3.10	$5.08	$2.36
Weighted Average Basic Shares Outstanding	115.08M	115.51M	115.77M	116.05M	116.31M	233.40M	234.60M	236.40M	238.20M	239.80M	231.20M
Diluted Earnings per Share	$1.87	$2.19	$2.26	$1.83	$1.63	($10.50)	($7.10)	($4.52)	$2.68	$4.12	$2.08
Weighted Average Diluted Shares Outstanding	115.40M	115.78M	116.06M	116.34M	116.61M	233.40M	234.60M	236.40M	304M	309.80M	268.60M
Weighted Average Basic & Diluted Shares Outstanding	116M	116.50M	116.90M	116.80M	117.40M	118.58M	119.74M	120.59M	184.15K	184.15K	115.71M
Cash Dividends to Common per Share	$1.00	$1.08	$1.16	$1.28	$1.36	$0.36	-	-	-	-	$0.33

This table shows Cinemark's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	90	-18	25	46	188	51	-39	94	50	34	-6.40
Consolidated Net Income / (Loss)	190	156	0.00	98	379	474	-73	195	112	56	-11
Net Income / (Loss) Continuing Operations	64	22	481	36	243	-328	-117	99	80	-46	-68
Total Pre-Tax Income	229	190	0.00	95	296	382	-102	281	113	224	-19
Total Operating Income	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Gross Profit	659	445	579	540	702	425	360	722	645	566	454
Total Revenue	875	639	579	734	922	814	541	941	858	776	643
Operating Revenue	875	639	579	734	922	814	541	941	858	776	643
Total Cost of Revenue	216	194	0.00	195	220	389	181	219	213	210	189
Operating Cost of Revenue	216	194	0.00	195	220	389	181	219	213	210	189
Total Operating Expenses	512	488	49	469	513	914	468	507	531	545	495
Selling, General & Admin Expense	355	334	0.00	320	366	666	319	357	378	384	341
Marketing Expense	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Depreciation Expense	156	150	49	149	147	246	149	148	153	156	155
Other Special Charges / (Income)	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Total Other Income / (Expense), net	-44	100	-49	-37	-28	69	-39	-30	-33	-40	-35
Interest Expense	38	-52	49	46	48	-0.70	39	50	43	43	35
Income Tax Expense	39	34	0.00	-2.20	-82	-91	-29	86	0.90	27	-7.60
Net Income / (Loss) Attributable to Noncontrolling Interest	2.00	0.80	0.00	1.60	2.20	2.60	0.60	2.40	2.00	1.60	1.20
Basic Earnings per Share	$1.48	($0.28)	$0.40	$0.74	$3.08	$1.06	($0.64)	$1.62	$0.86	$0.52	($0.12)
Weighted Average Basic Shares Outstanding	238.40M	238.20M	119.50M	239.80M	240M	239.80M	238.80M	227M	227.60M	231.20M	229.40M
Diluted Earnings per Share	$1.22	($0.08)	$0.38	$0.64	$2.38	$0.91	($0.64)	$1.26	$0.80	$0.66	($0.12)
Weighted Average Diluted Shares Outstanding	304M	304M	152.40M	306.80M	316.40M	309.80M	238.80M	298.20M	247.60M	268.60M	229.40M
Weighted Average Basic & Diluted Shares Outstanding	121.80M	184.15K	122.53M	184.15K	184.15K	184.15K	115.20M	115.22M	117.66M	115.71M	116.97M
Cash Dividends to Common per Share	-	-	-	-	-	-	$0.08	$0.08	$0.08	-	$0.09

This table details how cash moves in and out of Cinemark's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-50	-27	-39	-96	62	-61	602	36	360	518	-1,256
Net Cash From Operating Activities	456	463	529	557	562	-665	343	289	899	939	804
Net Cash From Continuing Operating Activities	456	463	529	557	562	-1,245	696	360	857	1,018	745
Net Income / (Loss) Continuing Operations	219	257	266	215	194	-1,843	-422	-268	400	637	290
Consolidated Net Income / (Loss)	219	257	266	215	194	-1,843	-422	-268	400	637	290
Depreciation Expense	187	207	235	258	256	510	525	471	415	391	403
Amortization Expense	9.82	-7.43	-5.32	-10	-3.32	-50	-32	-33	-56	-75	-45
Non-Cash Adjustments To Reconcile Net Income	22	39	38	77	91	177	154	250	44	49	148
Changes in Operating Assets and Liabilities, net	19	-33	-5.06	17	25	-39	471	-61	55	15	-51
Net Cash From Investing Activities	-328	-328	-410	-451	-311	-167	-179	-193	-264	-294	-418
Net Cash From Continuing Investing Activities	-328	-328	-410	-451	-311	-251	-179	-193	-264	-294	-418
Purchase of Property, Plant & Equipment	-332	-327	-381	-346	-304	-252	-191	-221	-299	-302	-438
Sale of Property, Plant & Equipment	9.97	3.57	15	3.92	3.16	1.20	12	29	5.80	6.60	19
Divestitures	-	-	-	-	-	-	0.00	0.00	30	0.00	0.00
Other Investing Activities, net	-	-1.45	-	-	-	-	-	0.00	0.00	1.20	0.00
Net Cash From Financing Activities	-151	-164	-158	-193	-187	779	80	-104	-251	-206	-1,609
Net Cash From Continuing Financing Activities	-151	-164	-158	-193	-187	451	95	-90	-236	-191	-1,593
Repayment of Debt	-32	-254	-8.46	-15	-10	-47	-2,365	-67	-1,497	-1,166	-476
Repurchase of Common Equity	-	-	-	-	-	0.00	-8.20	-8.60	-5.80	-9.80	-409
Payment of Dividends	-116	-126	-135	-149	-159	0.00	-	-	0.00	0.00	-39
Issuance of Debt	1.38	223	-	0.00	0.00	545	2,367	0.00	1,280	1,000	0.00
Other Financing Activities, net	-4.77	-6.83	-14	-28	-17	-46	101	-14	-14	-15	-669
Effect of Exchange Rate Changes	-27	1.27	-	-9.22	-2.76	-7.80	-10	-41	-	-16	26

This table details how cash moves in and out of Cinemark's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	103	-173	-115	84	91	79	-498	415	-955	-218	-165
Net Cash From Operating Activities	177	215	-39	366	222	390	-230	551	187	296	-41
Net Cash From Continuing Operating Activities	154	-62	-47	442	23	210	-232	502	159	312	-50
Net Income / (Loss) Continuing Operations	190	-244	53	98	379	-217	-73	195	112	56	-11
Consolidated Net Income / (Loss)	190	-244	53	98	379	-217	-73	195	112	56	-11
Depreciation Expense	103	99	98	98	97	97	99	99	101	104	103
Amortization Expense	1.00	-60	-2.20	-19	-19	-20	5.20	-27	-11	-12	4.40
Non-Cash Adjustments To Reconcile Net Income	-41	13	-21	14	-69	78	10	1.60	61	71	13
Changes in Operating Assets and Liabilities, net	-99	130	-174	250	-365	271	-273	233	-105	93	-160
Net Cash From Investing Activities	-41	-114	-47	-46	-85	-116	-31	-60	-107	-221	-75
Net Cash From Continuing Investing Activities	-41	-114	-47	-46	-85	-116	-31	-60	-107	-221	-75
Purchase of Property, Plant & Equipment	-70	-120	-47	-47	-86	-121	-44	-60	-107	-227	-75
Sale of Property, Plant & Equipment	30	-24	0.40	-	0.60	5.60	14	0.40	-	5.40	0.40
Net Cash From Financing Activities	-14	-15	-21	-315	147	-17	-251	-23	-1,032	-303	-74
Net Cash From Continuing Financing Activities	-18	5.10	-25	-304	151	-13	-254	-12	-1,028	-299	-67
Repayment of Debt	-7.00	-12	-5.00	-307	-845	-8.00	1.20	-6.00	-466	-5.30	-4.10
Repurchase of Common Equity	-0.20	-0.80	-8.40	-0.40	-	-1.00	-234	-0.60	-40	-135	-41
Payment of Dividends	-	-	0.00	-	-	-	-9.90	-9.20	-518	499	-11
Other Financing Activities, net	-11	18	-11	3.60	-3.90	-3.90	-11	3.80	-3.90	-657	-12
Other Net Changes in Cash	-19	-	-8.20	-	-	-	13	-	-	-	24

This table presents Cinemark's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	4,126	4,307	4,471	4,482	5,828	5,563	0.00	9,441	9,493	9,963	8,906
Total Current Assets	715	676	658	559	635	893	0.00	1,533	1,939	2,427	1,284
Cash & Equivalents	589	561	523	426	488	655	0.00	1,102	1,462	1,885	688
Accounts Receivable	74	75	89	95	84	25	0.00	243	217	274	313
Inventories, net	16	17	18	19	22	13	0.00	47	47	62	58
Prepaid Expenses	13	16	17	15	37	34	0.00	51	101	98	95
Current Deferred & Refundable Income Taxes	23	7.37	12	3.29	4.08	165	0.00	90	113	109	130
Plant, Property, & Equipment, net	1,505	1,705	1,828	1,833	1,735	1,615	1,383	1,232	1,162	1,145	2,352
Total Noncurrent Assets	1,906	1,926	1,985	2,090	3,458	3,055	3,061	2,786	2,690	2,775	4,025
Long-Term Investments	95	98	120	157	421	176	271	64	83	110	82
Goodwill	1,248	1,263	1,284	1,276	1,283	1,254	1,249	1,251	1,251	1,240	1,246
Intangible Assets	340	335	337	331	322	314	311	305	303	301	601
Noncurrent Deferred & Refundable Income Taxes	2.11	2.05	4.07	9.03	9.37	0.00	0.00	0.00	15	137	143
Other Noncurrent Operating Assets	222	228	240	317	1,422	1,311	1,231	1,166	1,037	987	1,953
Total Liabilities & Shareholders' Equity	4,126	4,307	4,471	4,482	5,828	5,563	0.00	9,441	9,493	9,963	8,906
Total Liabilities	3,016	3,034	3,065	3,073	4,380	4,764	2,330	7,447	7,181	7,069	8,037
Total Current Liabilities	440	443	469	475	709	606	0.00	1,409	1,453	2,094	1,692
Short-Term Debt	27	27	33	35	6.60	227	217	241	228	683	443
Accounts Payable	109	110	110	105	92	71	0.00	144	107	172	1,207
Current Deferred & Payable Income Tax Liabilities	16	15	17	13	19	5.63	0.00	6.40	8.40	8.00	9.20
Other Current Liabilities	-	-	-	-	233	16	15	14	14	15	33
Total Noncurrent Liabilities	2,576	2,590	2,596	2,599	3,671	4,158	1,873	6,472	6,194	5,472	6,345
Long-Term Debt	1,773	1,782	1,780	1,773	1,771	2,377	0.00	4,497	4,328	3,741	3,738
Capital Lease Obligations	209	234	251	232	141	1,263	1,181	1,059	927	894	1,769
Noncurrent Deferred Revenue	385	386	41	39	348	344	-	676	657	637	614
Noncurrent Deferred & Payable Income Tax Liabilities	148	143	130	154	143	99	0.00	166	199	111	127
Other Noncurrent Operating Liabilities	61	44	394	401	1,267	75	692	75	82	89	96
Total Equity & Noncontrolling Interests	1,111	1,273	1,406	1,409	1,448	799	0.00	501	919	1,503	869
Total Preferred & Common Equity	1,100	1,262	1,394	1,396	1,436	788	0.00	483	901	1,485	852
Total Common Equity	1,100	1,262	1,394	1,396	1,436	788	-91	507	925	1,509	876
Common Stock	1,113	1,129	1,141	1,156	1,170	1,246	0.00	2,748	2,797	2,861	3,017
Retained Earnings	325	454	582	639	687	28	0.00	-1,437	-1,043	-412	-822
Treasury Stock	-67	-73	-76	-79	-82	-87	-91	-95	-98	-103	-540
Accumulated Other Comprehensive Income / (Loss)	-272	-247	-253	-319	-340	-399	0.00	-710	-731	-836	-779
Noncontrolling Interest	11	11	12	12	13	11	12	9.30	9.00	9.00	17

This table presents Cinemark's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	4,851	0.00	9,512	9,446	9,393	9,402	9,704	9,429	9,902	8,908	8,751
Total Current Assets	801	0.00	1,769	1,846	1,801	1,846	2,110	1,855	2,399	1,447	1,081
Cash & Equivalents	632	0.00	1,274	1,377	1,347	1,344	1,630	1,387	1,860	922	523
Accounts Receivable	52	0.00	232	201	212	250	248	229	286	255	275
Inventories, net	20	0.00	55	54	47	53	59	62	66	60	65
Prepaid Expenses	52	0.00	117	116	89	103	95	86	98	95	93
Current Deferred & Refundable Income Taxes	45	0.00	90	98	105	96	79	91	88	114	125
Plant, Property, & Equipment, net	1,260	0.00	2,376	2,309	2,319	2,252	2,242	2,245	2,237	2,252	2,347
Total Noncurrent Assets	2,818	1,569	3,807	3,740	3,721	3,759	3,805	3,785	3,721	3,661	4,075
Long-Term Investments	26	11	78	87	97	92	121	96	88	86	72
Goodwill	1,249	1,253	1,256	1,249	1,249	1,244	1,246	1,243	1,245	1,247	1,248
Intangible Assets	309	304	304	303	302	302	301	301	301	300	601
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	60	69	134	203	152	146	179
Other Noncurrent Operating Assets	1,233	0.00	2,170	2,101	2,012	2,052	2,003	1,942	1,935	1,882	1,976
Total Liabilities & Shareholders' Equity	4,851	0.00	9,512	9,446	9,393	9,402	9,704	9,429	9,902	8,908	8,751
Total Liabilities	4,645	672	8,728	8,494	8,434	8,360	8,275	8,184	8,444	7,950	7,909
Total Current Liabilities	628	0.00	1,481	1,301	1,325	1,553	1,852	1,801	2,082	1,659	1,571
Short-Term Debt	240	0.00	16	16	16	15	470	472	472	476	13
Accounts Payable	372	0.00	993	823	853	1,080	922	862	1,142	1,041	1,074
Current Deferred & Payable Income Tax Liabilities	2.40	0.00	5.00	4.20	11	4.60	3.60	12	5.80	9.00	18
Other Current Liabilities	15	0.00	467	458	446	453	457	456	462	133	467
Total Noncurrent Liabilities	4,017	672	7,247	7,193	7,109	6,807	6,423	6,383	6,363	6,292	6,338
Long-Term Debt	2,474	0.00	4,328	4,328	4,328	4,030	3,741	3,740	3,741	3,739	3,738
Capital Lease Obligations	1,079	0.00	161	154	191	184	188	212	204	1,712	179
Noncurrent Deferred Revenue	-	-	667	662	652	648	642	631	626	620	609
Noncurrent Deferred & Payable Income Tax Liabilities	87	0.00	169	191	174	162	110	117	119	123	133
Other Noncurrent Operating Liabilities	377	672	1,922	1,859	1,764	1,784	1,741	1,683	1,673	98	1,679
Total Equity & Noncontrolling Interests	205	0.00	784	1,001	1,008	1,092	1,429	1,244	1,458	1,007	842
Total Preferred & Common Equity	195	0.00	764	932	941	1,024	1,410	1,228	1,440	939	825
Total Common Equity	195	-98	788	956	965	1,048	1,434	1,252	1,464	964	849
Common Stock	1,214	0.00	2,773	2,785	2,810	2,828	2,843	2,878	2,893	2,938	3,035
Retained Earnings	-561	0.00	-1,195	-1,007	-991	-895	-518	-496	-313	-721	-856
Treasury Stock	-95	-98	-98	-98	-103	-103	-103	-322	-322	-464	-560
Accumulated Other Comprehensive Income / (Loss)	-363	0.00	-693	-725	-751	-782	-788	-809	-794	-789	-770
Noncontrolling Interest	11	0.00	20	20	18	18	19	17	18	18	17

This table displays calculated financial ratios and metrics derived from Cinemark's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.59%	2.32%	2.49%	7.69%	1.90%	-100.00%	0.00%	62.51%	24.93%	-0.56%	2.15%
EBITDA Growth	11.36%	3.62%	-0.68%	0.02%	-6.07%	-285.93%	142.05%	-9.88%	-28.95%	-1.36%	14.13%
EBIT Growth	13.07%	4.60%	-7.76%	-4.27%	-11.28%	-553.36%	98.52%	33.33%	-269.23%	66.32%	-1.03%
NOPAT Growth	9.63%	13.13%	0.32%	-10.94%	-10.95%	-557.93%	100.00%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	12.75%	17.42%	3.58%	-19.06%	-9.97%	-1,050.80%	33.56%	37.55%	177.36%	60.56%	-54.47%
EPS Growth	12.65%	17.11%	3.20%	-19.03%	-10.93%	-744.17%	32.38%	36.34%	159.29%	53.73%	-49.51%
Operating Cash Flow Growth	0.27%	1.54%	14.28%	5.28%	0.91%	-218.33%	151.52%	-15.53%	210.68%	4.42%	-14.34%
Free Cash Flow Firm Growth	76.95%	-67.30%	63.56%	74.90%	180.77%	-482.09%	123.96%	-14.29%	-63.53%	-128.44%	-77.04%
Invested Capital Growth	0.82%	9.05%	6.41%	1.36%	-14.23%	56.01%	-15.46%	-15.67%	-6.78%	2.07%	3.59%
Revenue Q/Q Growth	1.69%	-0.22%	1.67%	1.53%	-0.29%	-100.00%	968.76%	12.83%	-12.08%	6.10%	-1.21%
EBITDA Q/Q Growth	1.16%	-3.93%	1.65%	1.99%	-2.95%	-627.96%	162.58%	-33.27%	-20.05%	39.91%	2.11%
EBIT Q/Q Growth	2.77%	-2.88%	-0.09%	-0.62%	-5.06%	-298.61%	98.38%	-107.04%	-18.28%	70.11%	-60.66%
NOPAT Q/Q Growth	1.38%	8.18%	8.03%	-23.43%	5.46%	-290.37%	100.00%	-100.00%	-100.00%	0.00%	0.00%
Net Income Q/Q Growth	5.09%	8.01%	7.34%	-25.95%	3.63%	-424.45%	35.33%	40.03%	293.61%	50.28%	-59.05%
EPS Q/Q Growth	5.06%	8.96%	6.60%	-25.91%	3.16%	-251.17%	34.74%	29.04%	143.64%	31.63%	-2.80%
Operating Cash Flow Q/Q Growth	-0.43%	-8.84%	6.59%	-1.85%	-6.97%	-23,046.54%	159.97%	-41.08%	0.08%	22.80%	-10.46%
Free Cash Flow Firm Q/Q Growth	165.51%	-57.78%	89.69%	15.16%	164.71%	-254.00%	165.52%	153.38%	-81.39%	45.10%	94.82%
Invested Capital Q/Q Growth	-4.00%	1.21%	-0.29%	-4.05%	-41.68%	64.80%	46.59%	-18.84%	4.71%	2.82%	-37.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	73.18%	72.54%	71.62%	72.43%	70.68%	0.00%	69.16%	69.63%	73.71%	73.65%	73.61%
EBITDA Margin	21.78%	22.05%	21.37%	19.85%	18.30%	0.00%	31.09%	17.24%	9.81%	9.73%	10.87%
Operating Margin	14.83%	14.49%	13.11%	12.05%	10.31%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	14.88%	15.21%	13.69%	12.17%	10.60%	0.00%	-1.55%	-0.64%	-1.88%	-0.64%	-0.63%
Profit (Net Income) Margin	7.67%	8.80%	8.89%	6.68%	5.90%	0.00%	-81.07%	-31.15%	19.29%	31.15%	9.31%
Tax Burden Percent	62.91%	71.21%	77.02%	69.29%	70.81%	66.65%	94.89%	99.08%	87.03%	122.74%	56.09%
Interest Burden Percent	81.90%	81.22%	84.32%	79.25%	78.70%	175.35%	5,514.53%	4,947.44%	-1,180.21%	-3,989.18%	-2,637.76%
Effective Tax Rate	37.09%	28.79%	22.98%	30.71%	29.19%	0.00%	0.00%	0.00%	12.97%	-22.74%	16.54%
Return on Invested Capital (ROIC)	10.97%	11.83%	11.02%	9.45%	9.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	7.34%	8.55%	8.44%	5.72%	5.29%	0.00%	-39.01%	-27.94%	30.64%	69.66%	19.84%
Return on Net Nonoperating Assets (RNNOA)	8.61%	9.72%	8.84%	5.85%	4.57%	0.00%	-306.52%	-305.03%	83.29%	78.43%	24.45%
Return on Equity (ROE)	19.58%	21.55%	19.86%	15.30%	13.57%	-164.03%	-306.52%	-305.03%	83.29%	78.43%	24.45%
Cash Return on Invested Capital (CROIC)	10.16%	3.17%	4.81%	8.10%	24.32%	-78.63%	16.75%	17.01%	7.02%	-2.05%	-3.52%
Operating Return on Assets (OROA)	10.29%	10.53%	9.33%	8.76%	6.75%	0.00%	-0.84%	-0.33%	-0.61%	-0.20%	-0.21%
Return on Assets (ROA)	5.30%	6.09%	6.06%	4.81%	3.76%	0.00%	-44.02%	-16.20%	6.25%	9.76%	3.07%
Return on Common Equity (ROCE)	19.39%	21.35%	19.69%	15.17%	13.45%	-162.31%	-267.35%	-253.01%	83.99%	78.83%	24.58%
Return on Equity Simple (ROE_SIMPLE)	19.89%	20.35%	19.09%	15.42%	13.50%	-233.90%	0.00%	-158.39%	65.65%	63.96%	0.00%
Net Operating Profit after Tax (NOPAT)	266	301	302	269	240	-1,097	0.00	0.00	0.00	0.00	0.00
NOPAT Margin	9.33%	10.32%	10.10%	8.35%	7.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	3.63%	3.27%	2.58%	3.74%	3.71%	36.88%	39.01%	27.94%	-30.64%	-69.66%	-19.84%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	0.00%	0.00%	0.00%	0.00%
Cost of Revenue to Revenue	26.82%	27.46%	28.38%	27.57%	29.32%	0.00%	30.84%	30.37%	26.29%	26.35%	26.39%
SG&A Expenses to Revenue	17.97%	17.11%	16.99%	19.03%	19.74%	0.00%	58.62%	47.53%	43.30%	44.31%	46.17%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	58.34%	58.05%	58.51%	60.38%	60.37%	0.00%	112.64%	83.71%	64.34%	63.79%	65.82%
Earnings before Interest and Taxes (EBIT)	424	444	410	392	348	-1,577	-23	-16	-58	-19	-20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	621	644	639	639	601	-1,117	470	423	301	297	339
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	2.72	2.61	0.00	3,147.46	1.85	0.00	3.12
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	1.19	0.00	1.28	650.09	0.56	0.00	0.88
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	20.41	0.00	0.00	0.00	9.12	0.02	19.79
Dividend Yield	3.46%	3.16%	3.63%	3.77%	4.08%	7.93%	0.00%	0.00%	0.00%	0.00%	1.42%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	4.90%	0.00%	0.00%	0.00%	10.97%	5,428.66%	5.05%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	2.01	1.33	0.95	585.46	2.22	1.28	2.53
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	1.50	0.00	2.03	651.98	1.85	1.09	2.19
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	8.21	0.00	6.53	3,781.67	18.83	11.25	20.16
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	14.17	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	20.57	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	8.77	0.00	8.95	5,530.08	6.30	3.55	8.49
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	7.61	0.00	5.17	3,149.78	30.56	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.81	1.61	1.47	1.45	1.32	4.84	0.00	11.56	5.97	3.54	5.58
Long-Term Debt to Equity	1.78	1.58	1.45	1.42	1.32	4.56	0.00	11.08	5.72	3.08	5.32
Financial Leverage	1.17	1.14	1.05	1.02	0.86	1.80	7.86	10.92	2.72	1.13	1.23
Leverage Ratio	3.69	3.54	3.28	3.18	3.61	5.07	6.96	18.83	13.33	8.03	7.95
Compound Leverage Factor	3.02	2.87	2.76	2.52	2.84	8.89	383.96	931.57	-157.31	-320.42	-209.79
Debt to Total Capital	64.40%	61.62%	59.49%	59.16%	56.99%	82.88%	100.00%	92.04%	85.64%	77.96%	84.80%
Short-Term Debt to Total Capital	0.87%	0.81%	0.94%	1.02%	0.20%	4.86%	15.53%	3.82%	3.56%	10.01%	3.98%
Long-Term Debt to Total Capital	63.52%	60.81%	58.55%	58.14%	56.79%	78.02%	84.47%	88.22%	82.08%	67.95%	80.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.36%	0.34%	0.34%	0.36%	0.37%	0.24%	0.83%	0.15%	0.14%	0.13%	0.15%
Common Equity to Total Capital	35.25%	38.05%	40.17%	40.48%	42.64%	16.89%	-6.52%	8.05%	14.45%	22.13%	15.32%
Debt to EBITDA	3.23	3.17	3.23	3.19	3.19	-3.46	2.98	13.70	18.24	17.93	14.33
Net Debt to EBITDA	2.13	2.15	2.22	2.28	1.68	-2.72	2.40	10.94	13.10	11.20	12.06
Long-Term Debt to EBITDA	3.19	3.13	3.18	3.14	3.18	-3.26	2.51	13.13	17.48	15.63	13.66
Debt to NOPAT	7.55	6.79	6.83	7.58	8.01	-3.52	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	4.98	4.60	4.70	5.42	4.21	-2.77	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	7.44	6.70	6.72	7.45	7.98	-3.32	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.00	0.00	0.00	1.45	-0.61	0.00	128.62	0.35	0.28	0.41
Noncontrolling Interest Sharing Ratio	0.96%	0.93%	0.86%	0.86%	0.87%	1.05%	12.78%	17.05%	-0.83%	-0.51%	-0.56%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.53	1.40	1.18	0.90	1.47	0.00	1.09	1.33	1.16	0.76
Quick Ratio	1.51	1.44	1.30	1.10	0.81	1.12	0.00	0.95	1.16	1.03	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	247	81	132	231	647	-2,474	593	508	185	-53	-93
Operating Cash Flow to CapEx	141.68%	143.17%	144.63%	162.77%	187.04%	-265.47%	191.83%	150.26%	306.65%	318.24%	192.21%
Free Cash Flow to Firm to Interest Expense	2.17	0.66	1.24	1.76	5.04	-6.59	3.97	2.52	0.95	-0.28	-0.50
Operating Cash Flow to Interest Expense	4.01	3.80	4.97	4.24	4.37	-1.77	2.30	1.43	4.60	4.99	4.35
Operating Cash Flow Less CapEx to Interest Expense	1.18	1.15	1.53	1.64	2.03	-2.44	1.10	0.48	3.10	3.42	2.09
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.69	0.69	0.68	0.72	0.64	0.00	0.54	0.52	0.32	0.31	0.33
Accounts Receivable Turnover	46.69	39.10	36.43	34.96	36.72	0.00	0.00	0.00	13.34	12.42	10.62
Inventory Turnover	52.10	48.70	49.26	48.23	46.95	16.92	0.00	0.00	17.15	14.80	13.68
Fixed Asset Turnover	1.93	1.82	1.69	1.76	1.84	0.00	1.01	1.88	2.56	2.64	2.68
Accounts Payable Turnover	6.71	7.32	7.71	8.28	9.81	3.57	0.00	0.00	6.42	5.76	4.78
Days Sales Outstanding (DSO)	7.82	9.33	10.02	10.44	9.94	0.00	0.00	0.00	27.37	29.40	34.38
Days Inventory Outstanding (DIO)	7.01	7.49	7.41	7.57	7.77	21.57	0.00	0.00	21.28	24.66	26.68
Days Payable Outstanding (DPO)	54.39	49.87	47.32	44.10	37.21	102.11	0.00	0.00	56.82	63.32	76.40
Cash Conversion Cycle (CCC)	-39.56	-33.04	-29.89	-26.09	-19.49	0.00	0.00	0.00	-8.17	-9.26	-15.34
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,436	2,657	2,827	2,866	2,458	3,835	3,242	2,734	2,548	2,601	2,694
Invested Capital Turnover	1.18	1.15	1.09	1.13	1.23	0.00	0.43	0.82	1.16	1.18	1.18
Increase / (Decrease) in Invested Capital	20	221	170	38	-408	1,377	-593	-508	-185	53	93
Enterprise Value (EV)	0.00	0.00	0.00	0.00	4,929	5,104	3,067	1,600,404	5,664	3,337	6,824
Market Capitalization	0.00	0.00	0.00	0.00	3,906	2,057	1,928	1,595,765	1,716	5.70	2,734
Book Value per Share	$9.49	$10.86	$11.97	$11.95	$12.26	$6.67	($0.76)	$0.00	$7.60	$8,196.12	$7.45
Tangible Book Value per Share	($4.21)	($2.89)	($1.95)	($1.81)	($1.45)	($6.60)	($13.80)	($0.01)	($5.16)	($167.26)	($5.69)
Total Capital	3,120	3,316	3,470	3,449	3,367	4,666	1,398	6,298	6,402	6,821	5,720
Total Debt	2,009	2,044	2,064	2,040	1,919	3,867	1,398	5,796	5,483	5,318	4,851
Total Long-Term Debt	1,982	2,017	2,032	2,005	1,912	3,640	1,181	5,556	5,255	4,635	4,623
Net Debt	1,326	1,384	1,422	1,457	1,010	3,036	1,127	4,630	3,938	3,322	4,081
Capital Expenditures (CapEx)	322	323	366	342	300	251	179	193	293	295	418
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-286	-301	-301	-307	-556	-142	217	-737	-747	-869	-868
Debt-free Net Working Capital (DFNWC)	303	260	221	119	-67	513	217	365	715	1,016	-180
Net Working Capital (NWC)	275	233	189	84	-74	286	0.00	124	486	333	-408
Net Nonoperating Expense (NNE)	47	44	36	54	46	746	1,225	765	-592	-950	-290
Net Nonoperating Obligations (NNO)	1,326	1,384	1,422	1,457	1,010	3,036	3,242	2,232	1,629	1,098	1,825
Total Depreciation and Amortization (D&A)	197	200	230	247	253	460	493	439	358	316	358
Debt-free, Cash-free Net Working Capital to Revenue	-10.03%	-10.32%	-10.07%	-9.52%	-16.92%	0.00%	14.37%	-30.03%	-24.36%	-28.49%	-27.87%
Debt-free Net Working Capital to Revenue	10.61%	8.90%	7.40%	3.71%	-2.05%	0.00%	14.37%	14.86%	23.30%	33.32%	-5.78%
Net Working Capital to Revenue	9.65%	7.99%	6.31%	2.62%	-2.25%	0.00%	0.00%	5.05%	15.86%	10.93%	-13.09%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.87	$2.19	$2.26	$1.83	$1.63	($5.25)	($3.55)	($4.52)	$3.10	$5.08	$2.36
Adjusted Weighted Average Basic Shares Outstanding	115.08M	115.51M	115.77M	116.05M	116.31M	116.67M	117.25M	236.40M	238.20M	239.80M	231.20M
Adjusted Diluted Earnings per Share	$1.87	$2.19	$2.26	$1.83	$1.63	($5.25)	($3.55)	($4.52)	$2.68	$4.12	$2.08
Adjusted Weighted Average Diluted Shares Outstanding	115.40M	115.78M	116.06M	116.34M	116.61M	116.67M	117.25M	236.40M	304M	309.80M	268.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.63	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	115.92M	120.83M	116.47M	117.05M	117.15M	118.58M	119.74M	120.59M	184.15K	184.15K	115.71M
Normalized Net Operating Profit after Tax (NOPAT)	277	318	331	318	288	-1,097	14	122	14	1.05	5.43
Normalized NOPAT Margin	9.71%	10.89%	11.08%	9.88%	8.79%	0.00%	0.92%	4.95%	0.47%	0.03%	0.17%
Pre Tax Income Margin	12.19%	12.36%	11.55%	9.64%	8.34%	0.00%	-85.43%	-31.44%	22.17%	25.38%	16.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.73	3.65	3.85	2.99	2.71	-4.20	-0.16	-0.08	-0.29	-0.10	-0.11
NOPAT to Interest Expense	2.34	2.47	2.84	2.05	1.86	-2.92	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.90	0.99	0.41	0.38	0.37	-4.87	-1.35	-1.03	-1.79	-1.67	-2.37
NOPAT Less CapEx to Interest Expense	-0.49	-0.18	-0.60	-0.56	-0.47	-3.59	-1.20	-0.95	-1.50	-1.57	-2.26
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	52.97%	49.04%	50.78%	69.43%	82.17%	0.00%	0.00%	0.00%	0.00%	0.00%	13.41%
Augmented Payout Ratio	52.97%	49.04%	50.78%	69.43%	82.17%	0.00%	-0.67%	-1.12%	0.98%	1.03%	154.52%

This table displays calculated financial ratios and metrics derived from Cinemark's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	115,710,385.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	115,710,385.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.06
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	34.50%	-39.74%	-5.16%	-22.08%	5.37%	27.45%	-6.65%	28.10%	-6.98%	-4.67%	18.94%
EBITDA Growth	-23.51%	-67.14%	9.09%	-42.25%	-13.17%	66.11%	9.83%	34.30%	10.68%	9.09%	3.46%
EBIT Growth	-121.33%	-72.57%	100.00%	0.00%	49.40%	1.44%	0.00%	84.13%	-73.33%	-925.00%	0.00%
NOPAT Growth	0.00%	-100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Growth	404.49%	154.63%	-100.00%	-59.69%	99.32%	203.85%	0.00%	100.10%	-70.35%	-65.49%	85.05%
EPS Growth	405.00%	95.18%	416.67%	-60.00%	95.08%	1,237.50%	-268.42%	96.88%	-66.39%	-8.33%	81.25%
Operating Cash Flow Growth	739.86%	0.33%	-265.68%	-24.26%	25.71%	80.92%	-488.75%	50.57%	-15.68%	-24.10%	82.36%
Free Cash Flow Firm Growth	180.79%	-68.33%	-225.03%	127.13%	-110.27%	-128.44%	91.11%	-203.64%	-1,774.79%	-77.04%	-100.28%
Invested Capital Growth	-27.75%	-6.78%	182.03%	-3.70%	3.94%	2.07%	5.74%	3.98%	71.15%	3.59%	10.87%
Revenue Q/Q Growth	-7.16%	-26.97%	-9.34%	26.76%	25.55%	-11.66%	-33.60%	73.94%	-8.83%	-9.47%	-17.16%
EBITDA Q/Q Growth	-27.07%	-15.58%	49.44%	-30.47%	9.66%	61.50%	6.06%	-33.62%	14.49%	5.26%	28.10%
EBIT Q/Q Growth	-39.50%	162.95%	100.00%	0.00%	29.41%	226.19%	-95.28%	-300.00%	-420.00%	21.15%	100.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-21.46%	-17.95%	-100.00%	0.00%	288.41%	25.09%	-115.39%	367.63%	-42.44%	-50.58%	-119.64%
EPS Q/Q Growth	-23.75%	-106.56%	337.50%	236.84%	271.88%	-61.76%	-170.33%	296.88%	-36.51%	-17.50%	-118.18%
Operating Cash Flow Q/Q Growth	-63.47%	21.97%	-118.15%	1,036.57%	-39.38%	75.54%	-159.07%	339.53%	-66.05%	58.01%	-113.73%
Free Cash Flow Firm Q/Q Growth	388.46%	-80.17%	5.25%	105.45%	-209.22%	45.10%	-172.11%	36.47%	-1,875.63%	94.82%	-207.82%
Invested Capital Q/Q Growth	2.35%	4.71%	-43.67%	-8.35%	10.47%	2.82%	1.57%	-9.88%	81.84%	-37.77%	8.71%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	75.33%	69.67%	100.00%	73.50%	76.16%	52.20%	66.60%	76.74%	75.21%	72.92%	70.64%
EBITDA Margin	8.07%	9.33%	13.88%	7.61%	6.65%	12.16%	19.42%	7.41%	9.31%	10.82%	16.73%
Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	-3.80%	3.27%	0.00%	-3.24%	-1.82%	2.60%	0.18%	-0.21%	-1.21%	-1.06%	0.00%
Profit (Net Income) Margin	21.72%	24.40%	0.00%	13.28%	41.08%	58.17%	-13.48%	20.74%	13.10%	7.15%	-1.69%
Tax Burden Percent	83.04%	82.01%	0.00%	102.31%	127.81%	123.91%	71.61%	69.38%	99.20%	24.73%	58.92%
Interest Burden Percent	-689.16%	909.57%	0.00%	-400.42%	-1,763.69%	1,803.30%	-10,180.00%	-14,060.00%	-1,088.46%	-2,736.59%	0.00%
Effective Tax Rate	16.96%	17.99%	0.00%	-2.31%	-27.81%	-23.91%	0.00%	30.62%	0.80%	12.21%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	8.27%	8.07%	0.00%	6.98%	29.90%	34.74%	-5.05%	18.40%	5.08%	3.80%	-0.63%
Return on Net Nonoperating Assets (RNNOA)	31.49%	21.95%	0.00%	10.40%	31.17%	39.11%	-6.47%	15.30%	9.22%	4.68%	-1.04%
Return on Equity (ROE)	31.49%	21.95%	0.00%	10.40%	31.17%	39.11%	-6.47%	15.30%	9.22%	4.68%	-1.04%
Cash Return on Invested Capital (CROIC)	34.32%	7.02%	-95.30%	3.77%	-3.87%	-2.05%	-5.58%	-3.90%	-52.48%	-3.52%	-10.31%
Operating Return on Assets (OROA)	-1.85%	1.06%	0.00%	-0.97%	-0.55%	0.82%	0.06%	-0.07%	-0.41%	-0.35%	0.00%
Return on Assets (ROA)	10.60%	7.90%	0.00%	3.97%	12.33%	18.24%	-4.31%	6.91%	4.44%	2.36%	-0.60%
Return on Common Equity (ROCE)	30.04%	22.13%	0.00%	10.18%	30.66%	39.31%	-6.37%	15.08%	9.08%	4.70%	-1.05%
Return on Equity Simple (ROE_SIMPLE)	16.12%	0.00%	62.49%	43.31%	44.85%	0.00%	71.45%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Nonoperating Expense Percent (NNEP)	-8.27%	-8.07%	0.00%	-6.98%	-29.90%	-34.74%	5.05%	-18.40%	-5.08%	-3.80%	0.63%
Return On Investment Capital (ROIC_SIMPLE)	-	0.00%	-	-	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Cost of Revenue to Revenue	24.67%	30.33%	0.00%	26.51%	23.84%	47.80%	33.40%	23.26%	24.79%	27.08%	29.36%
SG&A Expenses to Revenue	40.55%	52.28%	0.00%	43.56%	39.69%	81.74%	59.07%	37.94%	44.06%	49.49%	52.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	58.57%	76.41%	8.53%	63.91%	55.67%	112.18%	86.54%	53.87%	61.94%	70.18%	77.02%
Earnings before Interest and Taxes (EBIT)	-33	21	0.00	-24	-17	21	1.00	-2.00	-10	-8.20	0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	60	80	56	61	99	105	70	80	84	108
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.34	1.85	2.27	2.53	0.00	0.00	2.44	2.37	3.35	3.12	7.77
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.64	0.56	0.72	0.94	0.00	0.00	1.01	1.08	1.02	0.88	2.05
Price to Earnings (P/E)	4.20	9.12	10.13	18.55	0.02	0.02	12.40	11.84	20.78	19.79	38.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.32%	0.53%	0.86%	1.42%	1.19%
Earnings Yield	23.81%	10.97%	9.87%	5.39%	4,689.19%	5,428.66%	8.07%	8.45%	4.81%	5.05%	2.59%
Enterprise Value to Invested Capital (EV/IC)	2.17	2.22	2.12	2.38	1.06	1.28	2.27	2.50	1.89	2.53	3.40
Enterprise Value to Revenue (EV/Rev)	1.52	1.85	1.75	1.93	0.93	1.09	2.00	1.85	2.59	2.19	3.09
Enterprise Value to EBITDA (EV/EBITDA)	14.06	18.83	20.20	24.68	12.60	11.25	19.63	18.42	24.63	20.16	27.50
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	86.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	5.89	6.30	6.33	7.59	3.50	3.55	8.03	6.39	9.09	8.49	10.01
Enterprise Value to Free Cash Flow (EV/FCFF)	5.31	30.56	0.00	62.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	4.49	5.97	4.50	3.87	3.08	3.54	3.55	3.03	5.89	5.58	4.67
Long-Term Debt to Equity	4.48	5.72	4.48	3.86	2.75	3.08	3.18	2.71	5.41	5.32	4.65
Financial Leverage	3.81	2.72	2.36	1.49	1.04	1.13	1.28	0.83	1.82	1.23	1.67
Leverage Ratio	11.85	13.33	9.32	10.09	7.88	8.03	8.36	7.57	7.64	7.95	8.71
Compound Leverage Factor	-81.66	121.24	0.00	-40.38	-139.01	144.84	-850.60	-1,064.51	-83.18	-217.65	0.00
Debt to Total Capital	81.79%	85.64%	81.81%	79.48%	75.49%	77.96%	78.05%	75.18%	85.48%	84.80%	82.35%
Short-Term Debt to Total Capital	0.29%	3.56%	0.28%	0.29%	8.06%	10.01%	8.32%	8.04%	6.87%	3.98%	0.27%
Long-Term Debt to Total Capital	81.50%	82.08%	81.53%	79.20%	67.42%	67.95%	69.73%	67.14%	78.61%	80.82%	82.08%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.36%	0.14%	0.32%	0.35%	0.33%	0.13%	0.30%	0.31%	0.26%	0.15%	0.36%
Common Equity to Total Capital	17.39%	14.45%	17.41%	19.69%	24.60%	22.13%	22.09%	24.92%	13.90%	15.32%	17.80%
Debt to EBITDA	11.96	18.24	17.30	19.11	20.75	17.93	14.46	13.64	17.88	14.33	10.86
Net Debt to EBITDA	8.07	13.10	11.79	12.62	12.49	11.20	9.61	7.62	14.84	12.06	9.22
Long-Term Debt to EBITDA	11.92	17.48	17.24	19.04	18.53	15.63	12.91	12.18	16.44	13.66	10.83
Debt to NOPAT	73.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	49.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	73.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.44	0.38	0.39	0.39	0.25	0.30	0.48	0.57	0.45	0.41	0.66
Noncontrolling Interest Sharing Ratio	4.60%	-0.83%	13.97%	2.12%	1.63%	-0.51%	1.59%	1.49%	1.56%	-0.56%	-0.69%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.42	1.33	1.36	1.19	1.14	1.16	1.03	1.15	0.87	0.76	0.69
Quick Ratio	1.21	1.16	1.18	1.03	1.01	1.03	0.90	1.03	0.71	0.59	0.51
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	935	185	-1,613	88	-96	-53	-143	-91	-1,800	-93	-287
Operating Cash Flow to CapEx	434.98%	150.21%	-83.91%	772.57%	259.95%	337.11%	-752.29%	922.07%	175.28%	133.73%	-54.13%
Free Cash Flow to Firm to Interest Expense	24.53	0.00	-29.75	0.90	-2.62	0.00	-2.91	-1.82	-42.05	-2.18	-8.28
Operating Cash Flow to Interest Expense	4.64	0.00	-0.72	3.74	6.05	0.00	-4.67	11.03	4.37	6.91	-1.17
Operating Cash Flow Less CapEx to Interest Expense	3.57	0.00	-1.58	3.26	3.72	0.00	-5.29	9.83	1.88	1.74	-3.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.49	0.32	0.65	0.30	0.30	0.31	0.32	0.33	0.34	0.33	0.35
Accounts Receivable Turnover	27.51	13.34	0.00	11.72	12.81	12.42	13.64	12.00	12.54	10.62	12.75
Inventory Turnover	21.90	17.15	0.00	11.19	10.82	14.80	18.03	16.89	16.88	13.68	13.10
Fixed Asset Turnover	1.95	2.56	0.00	1.22	1.26	2.64	1.32	1.43	1.40	2.68	1.40
Accounts Payable Turnover	1.35	6.42	0.00	0.58	0.70	5.76	1.15	0.91	1.02	4.78	0.86
Days Sales Outstanding (DSO)	13.27	27.37	0.00	31.14	28.50	29.40	26.75	30.43	29.11	34.38	28.62
Days Inventory Outstanding (DIO)	16.67	21.28	0.00	32.62	33.73	24.66	20.25	21.61	21.62	26.68	27.87
Days Payable Outstanding (DPO)	271.21	56.82	0.00	626.31	523.73	63.32	317.94	402.12	357.85	76.40	425.42
Cash Conversion Cycle (CCC)	-241.27	-8.17	0.00	-562.54	-461.50	-9.26	-270.94	-350.08	-307.12	-15.34	-368.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,434	2,548	2,499	2,290	2,530	2,601	2,642	2,381	4,329	2,694	2,929
Invested Capital Turnover	1.20	1.16	1.79	1.21	1.16	1.18	1.17	1.38	0.92	1.18	1.16
Increase / (Decrease) in Invested Capital	-935	-185	1,613	-88	96	53	143	91	1,800	93	287
Enterprise Value (EV)	5,289	5,664	5,298	5,461	2,672	3,337	6,007	5,964	8,165	6,824	9,947
Market Capitalization	2,235	1,716	2,189	2,649	5.13	5.70	3,049	3,477	3,228	2,734	6,595
Book Value per Share	$7.85	$7.60	$8.07	$8.55	$7,785.59	$8,196.12	$5.11	$12.71	$8.36	$7.45	$2.45
Tangible Book Value per Share	($4.89)	($5.16)	($4.91)	($4.06)	($613.64)	($167.26)	($1.19)	($0.71)	($5.06)	($5.69)	($2.88)
Total Capital	5,499	6,402	5,543	5,321	5,827	6,821	5,668	5,875	6,934	5,720	4,772
Total Debt	4,497	5,483	4,535	4,229	4,399	5,318	4,423	4,417	5,927	4,851	3,930
Total Long-Term Debt	4,482	5,255	4,519	4,214	3,929	4,635	3,952	3,944	5,451	4,623	3,917
Net Debt	3,034	3,938	3,091	2,793	2,648	3,322	2,941	2,469	4,919	4,081	3,335
Capital Expenditures (CapEx)	41	143	47	47	85	116	31	60	107	221	75
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-816	-747	-855	-1,035	-903	-869	-861	-1,070	-658	-868	-1,000
Debt-free Net Working Capital (DFNWC)	561	715	492	309	727	1,016	526	790	265	-180	-477
Net Working Capital (NWC)	545	486	476	294	257	333	54	317	-212	-408	-490
Net Nonoperating Expense (NNE)	-190	-156	0.00	-98	-379	-474	73	-195	-112	-56	11
Net Nonoperating Obligations (NNO)	1,432	1,629	1,490	1,198	1,101	1,098	1,398	923	3,323	1,825	2,087
Total Depreciation and Amortization (D&A)	104	39	80	80	78	78	104	72	90	92	108
Debt-free, Cash-free Net Working Capital to Revenue	-23.40%	-24.36%	-28.17%	-36.60%	-31.41%	-28.49%	-28.60%	-33.26%	-20.86%	-27.87%	-31.07%
Debt-free Net Working Capital to Revenue	16.07%	23.30%	16.20%	10.92%	25.30%	33.32%	17.45%	24.54%	8.39%	-5.78%	-14.82%
Net Working Capital to Revenue	15.62%	15.86%	15.69%	10.39%	8.95%	10.93%	1.79%	9.86%	-6.71%	-13.09%	-15.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.48	($0.28)	$0.20	$0.74	$3.08	$1.06	($0.64)	$1.62	$0.86	$0.52	($0.12)
Adjusted Weighted Average Basic Shares Outstanding	238.40M	238.20M	119.50M	239.80M	240M	239.80M	238.80M	227M	227.60M	231.20M	229.40M
Adjusted Diluted Earnings per Share	$1.22	($0.08)	$0.19	$0.64	$2.38	$0.91	($0.64)	$1.26	$0.80	$0.66	($0.12)
Adjusted Weighted Average Diluted Shares Outstanding	304M	304M	152.40M	306.80M	316.40M	309.80M	238.80M	298.20M	247.60M	268.60M	229.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	121.80M	184.15K	122.53M	184.15K	184.15K	184.15K	115.20M	115.22M	117.66M	115.71M	116.97M
Normalized Net Operating Profit after Tax (NOPAT)	1.66	3.69	0.00	0.00	0.00	1.05	0.00	1.11	0.60	0.00	0.00
Normalized NOPAT Margin	0.19%	0.58%	0.00%	0.00%	0.00%	0.13%	0.00%	0.12%	0.07%	0.00%	0.00%
Pre Tax Income Margin	26.15%	29.75%	0.00%	12.98%	32.14%	46.95%	-18.83%	29.90%	13.20%	28.91%	-2.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.87	0.00	0.00	-0.24	-0.46	0.00	0.02	-0.04	-0.24	-0.19	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.94	0.00	-0.86	-0.73	-2.78	0.00	-0.60	-1.24	-2.74	-5.36	-2.16
NOPAT Less CapEx to Interest Expense	-1.07	0.00	-0.86	-0.48	-2.33	0.00	-0.62	-1.20	-2.50	-5.17	-2.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.41%	11.22%
Augmented Payout Ratio	3.59%	0.98%	1.74%	2.21%	1.52%	1.03%	26.86%	24.19%	38.89%	154.52%	72.53%

Financials Breakdown Chart

Key Financial Trends

Cinemark Holdings, Inc. (CNK) has shown a mix of growing revenue in some quarters and hefty cash outflows driven by capital expenditures, debt activity, and shareholder returns over the last four years. Below are the most notable trends and data-driven observations from the quarterly reports (Q1 2025 through Q4 2025, and the most recent 2022–2024 comparisons).

Strong operating cash flow in Q2 2025: Net cash from continuing operating activities was about $501.6 million, illustrating solid core cash generation even with theater operations tightening in a post-pandemic environment.
Free cash flow positivity in key quarters: Free cash flow (operating cash flow minus capital expenditures) was roughly $441 million in Q2 2025 and about $85 million in Q4 2025, indicating the ability to fund dividends and some debt reduction from ongoing operations in multiple periods.
Profitability revival in mid-2025: Q2 2025 consolidated net income reached about $195.1 million, with continuing operations around $99.4 million, signaling a rebound in quarterly earnings.
Earnings per share recovery in Q2 2025: Basic EPS about $1.62 and diluted EPS about $1.26, marking a meaningful improvement from earlier quarters in 2025.
Debt reduction activity in Q3 2025: Notable debt repayments (~$466.3 million) supported closer to a lighter near-term debt burden, although long-term liabilities remain elevated.
Solid cash balance in 2025: Cash and equivalents hovered around the $900 million to $1 billion level (e.g., $922.2 million in Q3 2025), giving a relatively strong liquidity cushion.
Revenue demonstrated mid-year strength: Q2 2025 revenue was about $940.5 million, approaching the high end of the recent quarterly range and signaling demand normalization relative to earlier quarters in 2024.
Dividend and shareholder returns: Cinemark continued paying a per-share dividend of $0.08, and buyback activity occurred (e.g., $134.8 million in Q4 2025), which can be favorable for shareholders but reduces cash on hand in the near term.
Capex remains a meaningful use of cash: Quarterly purchases of property, plant & equipment ranged roughly from $60 million to $226 million in 2025, reflecting ongoing theater investments and expansion as part of strategy (neutral to investors until more clarity on ROI emerges).
Significant financing cash outflows and large liability load: Net cash from financing activities was notably negative in several quarters (for example, around -$1.03 billion in Q3 2025), underscoring heavy debt-related and shareholder-return outflows. Total liabilities as of recent quarters sit near $8.1–8.3 billion, with long-term debt around $3.7–4.0 billion, indicating a high leverage profile that investors should monitor.

Overall, Cinemark has shown pockets of improving profitability and meaningful operating cash flow in parts of 2025, supported by debt repayments and a substantial cash balance. However, the company also reports persistent cash outflows from financing activities and a sizable liabilities base, with capital expenditures continuing to weigh on free cash flow. Retail investors may want to watch how these dynamics evolve going into 2026, particularly around theater-level recoveries, debt management, and the trajectory of free cash flow generation.

05/07/26 01:07 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Cinemark's Financials

When does Cinemark's financial year end?

According to the most recent income statement we have on file, Cinemark's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Cinemark's net income changed over the last 10 years?

Cinemark's net income appears to be on an upward trend, with a most recent value of $290 million in 2025, rising from $218.73 million in 2015. The previous period was $637 million in 2024. View Cinemark's forecast to see where analysts expect Cinemark to go next.

What is Cinemark's operating income?

Cinemark's total operating income in 2025 was $0.00, based on the following breakdown:

Total Gross Profit: $2.29 billion
Total Operating Expenses: $2.05 billion

How has Cinemark's revenue changed over the last 10 years?

Over the last 10 years, Cinemark's total revenue changed from $2.85 billion in 2015 to $3.12 billion in 2025, a change of 9.2%.

How much debt does Cinemark have?

Cinemark's total liabilities were at $8.04 billion at the end of 2025, a 13.7% increase from 2024, and a 166.5% increase since 2015.

How much cash does Cinemark have?

In the past 10 years, Cinemark's cash and equivalents has ranged from $0.00 in 2021 to $1.88 billion in 2024, and is currently $688.40 million as of their latest financial filing in 2025.

How has Cinemark's book value per share changed over the last 10 years?

Over the last 10 years, Cinemark's book value per share changed from 9.49 in 2015 to 7.45 in 2025, a change of -21.5%.

Related Companies

Financial statements for NYSE:CNK last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cinemark (CNK) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cinemark's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cinemark (CNK) Financials

Annual Income Statements for Cinemark

Quarterly Income Statements for Cinemark

Annual Cash Flow Statements for Cinemark

Quarterly Cash Flow Statements for Cinemark

Annual Balance Sheets for Cinemark

Quarterly Balance Sheets for Cinemark

Annual Metrics And Ratios for Cinemark

Quarterly Metrics And Ratios for Cinemark

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Cinemark's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools